amonafide has been researched along with Carcinoma, Anaplastic in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barlozzari, T; Braña, MF; Domínguez, G; Robinson, S; Romerdahl, C; Sáez, B | 1 |
| Burch, PA; Kovach, JS; Marschke, RF; O'Connell, MJ; Rubin, J; Schutt, AJ; Wieand, HS | 1 |
| Asbury, RF; Blessing, JA; Clarke-Pearson, D; Homesley, HD; Look, KY | 1 |
| Asbury, R; Blessing, JA; Buller, R; Look, KY; Lucci, JA | 1 |
3 trial(s) available for amonafide and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Advanced colorectal adenocarcinoma: treatment with amonafide.
Topics: Adenine; Antineoplastic Agents; Carcinoma; Colorectal Neoplasms; Humans; Imides; Intercalating Agents; Isoquinolines; Naphthalimides; Organophosphonates | 1994 |
A Gynecologic Oncology Group phase II study of amonafide (NSC 308847) in epithelial ovarian cancer.
Topics: Adenine; Adult; Aged; Antineoplastic Agents; Carcinoma; Female; Humans; Imides; Isoquinolines; Middle Aged; Naphthalimides; Organophosphonates; Ovarian Neoplasms | 1993 |
A phase II trial of amonafide in patients with nonsquamous cell carcinoma of the cervix. A Gynecologic Oncology Group study.
Topics: Adenine; Adult; Antineoplastic Agents; Carcinoma; Female; Humans; Imides; Isoquinolines; Middle Aged; Naphthalimides; Organophosphonates; Uterine Cervical Neoplasms | 1997 |
1 other study(ies) available for amonafide and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Synthesis of antitumor dendritic imides.
Topics: Antineoplastic Agents; Carcinoma; Cell Division; Colonic Neoplasms; Drug Design; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Humans; Imides; Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 2001 |